Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Heron Therapeutics Inc.
DescriptionIV, polysorbate 80-free formulation of aprepitant, a tachykinin receptor (TACR1; NK1R)antagonist
Molecular Target Tachykinin receptor (TACR1) (NK1R)
Mechanism of ActionTachykinin receptor (TACR1) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationEmesis
Indication DetailsPrevent chemotherapy induced nausea and vomiting (CINV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today